Status:
TERMINATED
Cyberknife Radiosurgery and Quality of Life
Lead Sponsor:
Stanford University
Conditions:
Bone Cancer
Central Nervous System Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to look at pain control and QOL improvement after treatment with CK Radiosurgery for spinal metastases.
Eligibility Criteria
Inclusion
- Patients with a spinal metastasis who will be treated with Cyberknife radiosurgery.
- There are no age or gender restrictions.
- There are no life expectancy restrictions.
- Karnofsky Performance Status greater than 40.
- Negative pregnancy test or clinically assessed as not pregnant.
- Ability to understand and the willingness to sign a written informed consent document.
Exclusion
- Patients with benign tumors will not be included (neurofibromas, schwannomas, etc.)
- Other investigational medications or treatments will be noted, but will not preclude inclusion.
- Pregnant or nursing patients will be not be included in the study due to radiation exposure.
Key Trial Info
Start Date :
July 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT01163539
Start Date
July 1 2010
End Date
June 1 2012
Last Update
July 1 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305